Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02616016

MRI Guided HIFU for Palliation of Painful Skeletal Metastases in Children

Magnetic Resonance-Guided High Intensity Focused Ultrasound for Palliation of Painful Skeletal Metastases in Children - A Pilot Study

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
The Hospital for Sick Children · Academic / Other
Sex
All
Age
5 Years – 17 Years
Healthy volunteers
Not accepted

Summary

The Philips Sonalleve MR-HIFU system is expected to be effective in reducing pain intensity and/or reducing analgesic use in patients with painful uncomplicated bone metastases. No serious adverse effects are expected to result from this treatment.

Detailed description

The objective of this study is to determine if MR-guided high intensity focused ultrasound (MR-HIFU) is an effective technique for alleviating the pain associated with bone metastases in paediatric cancer patients. This technique meant to be an adjunct therapy to the standard-of-care, which includes radiation therapy and chemotherapy. Safety of the technique will be assessed through evaluating non-targeted heating using MRI-based temperature mapping, and inspecting patients post-treatment for skin burns. or other signs of serious adverse events. Efficacy of the technique will be assessed by evaluating/recording patients observed pain, quality of life, and pain medication usage both before and up to 3 months following treatment.

Conditions

Interventions

TypeNameDescription
DEVICEMRI Guided High Intensity Focused UltrasoundTarget treatment of bone metastases using High Intensity Focused Ultrasound

Timeline

Start date
2014-04-01
Primary completion
2024-05-02
Completion
2024-05-02
First posted
2015-11-26
Last updated
2024-05-03

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT02616016. Inclusion in this directory is not an endorsement.